1H-Pyrido[3,4-b]indole-3-carboxylic acid, 1-(1,3-benzodioxol-4-yl)-2,3,4,9-tetrahydro-, methyl ester, (1R,3R)-

1H-Pyrido[3,4-b]indole-3-carboxylic acid, 1-(1,3-benzodioxol-4-yl)-2,3,4,9-tetrahydro-, methyl ester, (1R,3R)- Struktur
1367574-90-0
CAS-Nr.
1367574-90-0
Englisch Name:
1H-Pyrido[3,4-b]indole-3-carboxylic acid, 1-(1,3-benzodioxol-4-yl)-2,3,4,9-tetrahydro-, methyl ester, (1R,3R)-
Synonyma:
Tadalafil Impurity 77;1H-Pyrido[3,4-b]indole-3-carboxylic acid, 1-(1,3-benzodioxol-4-yl)-2,3,4,9-tetrahydro-, methyl ester, (1R,3R)-
CBNumber:
CB510709709
Summenformel:
C20H18N2O4
Molgewicht:
350.37
MOL-Datei:
1367574-90-0.mol

1H-Pyrido[3,4-b]indole-3-carboxylic acid, 1-(1,3-benzodioxol-4-yl)-2,3,4,9-tetrahydro-, methyl ester, (1R,3R)- Eigenschaften

Siedepunkt:
518.3±50.0 °C(Predicted)
Dichte
1.359±0.06 g/cm3(Predicted)
pka
16.82±0.60(Predicted)

Sicherheit

1H-Pyrido[3,4-b]indole-3-carboxylic acid, 1-(1,3-benzodioxol-4-yl)-2,3,4,9-tetrahydro-, methyl ester, (1R,3R)- Chemische Eigenschaften,Einsatz,Produktion Methoden

1H-Pyrido[3,4-b]indole-3-carboxylic acid, 1-(1,3-benzodioxol-4-yl)-2,3,4,9-tetrahydro-, methyl ester, (1R,3R)- Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


1H-Pyrido[3,4-b]indole-3-carboxylic acid, 1-(1,3-benzodioxol-4-yl)-2,3,4,9-tetrahydro-, methyl ester, (1R,3R)- Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 4)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Hubei Yangxin Medical Technology Co., Ltd. 15374522761
3003392093@qq.com China 7934 55
Hubei Qingbei Yunyan Pharmaceutical Technology Co., Ltd 18162595016
3287908757@qq.com China 9887 58
ShenZhen H&D Pharmaceutical Technology Co., LTD 18367470722 18367470722
2885785763@qq.com China 2751 58
Hubei Moco Chemical Co., Ltd. 18627753421 18627756402
3001009495@qq.com China 10450 58

  • 1H-Pyrido[3,4-b]indole-3-carboxylic acid, 1-(1,3-benzodioxol-4-yl)-2,3,4,9-tetrahydro-, methyl ester, (1R,3R)-
  • Tadalafil Impurity 77
  • 1367574-90-0
Copyright 2019 © ChemicalBook. All rights reserved